• Fathia Gadri Jaat
• Nadia Mohamed Kermani

The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, China, in December 2019. Since then, it has spread rapidly around the world and become global concern. This outbreak has attracted much attention in medical community due to severe morbidity and mortality worldwide. Coronaviruses (CoVs) are the largest group of known positive‐sense RNA viruses having an extensive range of natural hosts. Although several therapeutic agents have been evaluated for the treatment of Covid-19, but there is a lack of effective antiviral agents. In this brief review we summarize the current knowledge on viral structure, clinical features, immune response, management, and treatment options of Covid-19, which may improve our understanding of this infectious disease.

COVID-19, immunopathology, Immune response, SARS-CoV-2.

"Coronavirus infection: overview and immune response", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 10, page no.3266-3269, October-2020, Available :http://www.jetir.org/papers/JETIR2010425.pdf

"Coronavirus infection: overview and immune response", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 10, page no. pp3266-3269, October-2020, Available at : http://www.jetir.org/papers/JETIR2010425.pdf